Fabre-Kramer Submits NDA Amendment for EXXUA™ for Tre

/PRNewswire/ -- Fabre-Kramer Pharmaceuticals, Inc. (Fabre-Kramer) today announced that on December 23, 2022, it filed an NDA Amendment with the Food and Drug...

Related Keywords

California , United States , Houston , Texas , Stephen Kramer , Anitah Clayton , Stephena Stahl , University Of California , Linkedin , Department Of Psychiatry Neurobehavioral Sciences , Human Services , Drug Administration , Neuroscience Education Institute , University Of Virginia School Medicine , Us Department Of Health , Fabre Kramer Pharmaceuticals Inc , New Class , Novel Mechanism Uniquely , Directly Addresses Important Unmet , Fabre Kramer Pharmaceuticals , Major Depressive Disorder , Neurobehavioral Sciences , Virginia School , Nc ,